PŮVODNÍ PRÁCE / ORIGINAL PAPER Dávkování enoxaparinu a výskyt žilního trombembolismu u kriticky nemocných pacientů s covidem-19 – retrospektivní observační studie 222 | ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA / Anest intenziv Med. 2024;35(4):215-222 / www.aimjournal.cz 4. PMID: 34351721; PMCID: PMC8362594. 21. Sholzberg M, Tang GH, Rahhal H, AlHamzah M, Kreuziger LB, Áinle FN, et al; RAPID trial investigators. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021 Oct 14;375:n2400. doi: 10.1136/bmj.n2400. PMID: 34649864; PMCID: PMC8515466. 22. Jiménez D, García‑Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz‑Artacho P, et al. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta‑analysis. Chest. 2021 Mar;159(3):1182-1196. doi: 10.1016/j.chest.2020. 11. 005. Epub 2020 Nov 17. PMID: 33217420; PMCID: PMC7670889. 23. Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D‑dimer levels on admission to predict in‑hospital mortality in patients with Covid-19. J Thromb Haemost. 2020 Jun;18(6):1324-1329. doi: 10.1111/jth.14859. PMID: 32306492; PMCID: PMC7264730.
RkJQdWJsaXNoZXIy NDA4Mjc=